French breast implant manufacturer PIP’s decision to put dangerous gels in their products is one example of recent scandals involving medical devices.
The European Parliament wants greater scrutiny on the industry.
New legislation enforces stricter regulation and encourages innovation. In vitro diagnostic medical devices lead to better treatment and improve the health of EU citizens.
Check Also
Rapport du Sénat sur les Médicaments innovants | CONSOLIDER LE MODÈLE FRANÇAIS D’ACCÈS PRÉCOCE
Rapport d’information de M. Yves DAUDIGNY, Mmes Catherine DEROCHE et Véronique GUILLOTIN, fait au nom …